Market Cap
$9.0B
QGEN
QIAGEN N.V.
$44.75 ▲ +6.45%
Prev close $42.04Market cap$9.0B
ConsensusHold
12-mo target$46.27 (+3.4%)
▲ Neutral
Analyst conviction 5/10
Biotech & Drug Discovery
Snapshot
The big-picture read on QGEN right now — valuation, ownership and activity at a glance.
Cap Size
Mid Cap
Analyst Consensus
Hold (48%)
Price chart 30d +2.0%
Daily candles (open–high–low–close) with volume. Green = up day, red = down day.
No data for this timeframe.
Vol
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Sep 23, 2026 short_volume
Short Volume: QGEN — 67.2% short (0.5M / 0.8M)
Short: 506,887 | Exempt: 600 | TRF Vol: 753,784 | Short Ratio: 67.2% | Off-exchange volume (dark poo
Analyst ratings buy % +4.3%
How Wall Street rates the stock today, and the latest firm-by-firm actions.
48% rate it Buy or better · 23 analysts
Recent analyst actions
| Date | Firm | Action | Rating | Firm rating |
|---|---|---|---|---|
| Sep 9, 2026 | UBS | MAINTAIN | Neutral | 55% |
| Aug 10, 2026 | Citigroup | MAINTAIN | Neutral | 55% |
| Aug 7, 2026 | Barclays | MAINTAIN | Equal-Weight | 54% |
| Aug 7, 2026 | JP Morgan | MAINTAIN | Overweight | 55% |
| Jun 23, 2026 | Morgan Stanley | UPGRADE | Overweight | 55% |
| May 18, 2026 | Stifel | MAINTAIN | Hold | 54% |
| May 7, 2026 | TD Cowen | MAINTAIN | Hold | 56% |
| Apr 29, 2026 | JP Morgan | MAINTAIN | Overweight | 55% |
| Apr 29, 2026 | Citigroup | MAINTAIN | Neutral | 55% |
| Apr 29, 2026 | Barclays | MAINTAIN | Equal-Weight | 54% |
Monthly consensus history
| Period | Str. Buy | Buy | Hold | Sell | Str. Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Sep 1, 2026 | 5 | 6 | 12 | 0 | 0 | 48% | |
| Aug 1, 2026 | 5 | 7 | 10 | 0 | 0 | 55% | |
| Jul 1, 2026 | 5 | 6 | 11 | 0 | 0 | 50% | |
| Jun 1, 2026 | 5 | 5 | 13 | 0 | 0 | 43% | |
| May 1, 2026 | 5 | 6 | 13 | 0 | 0 | 46% | |
| Apr 1, 2026 | 4 | 7 | 13 | 0 | 0 | 46% | |
| Mar 1, 2026 | 4 | 6 | 14 | 0 | 0 | 42% | |
| Feb 1, 2026 | 4 | 6 | 14 | 0 | 0 | 42% |
Price targets
Where 15 covering analysts think QGEN trades over the next 12 months.
$46.27 +3.4% upside Hold
Current$44.75 Low$40.00 Median$47.00 High$50.00 15 analysts
$40.00$50.00
Analyst rating Buy· 2.3/5 as of Oct 2, 2026
Upcoming & catalyst events
Scheduled dates plus disclosed catalysts — earnings, dividends, enforcement, FDA and clinical-trial events. Colored dot = impact.
Sep 23, 2026
short_volume
Short Volume: QGEN — 67.2% short (0.5M / 0.8M)
Short: 506,887 | Exempt: 600 | TRF Vol: 753,784 | Short Ratio: 67.2% | Off-exchange volume (dark pool + OTC)
Sep 21, 2026
short_volume
Short Volume: QGEN — 64.9% short (0.4M / 0.5M)
Short: 354,429 | Exempt: 462 | TRF Vol: 545,978 | Short Ratio: 64.9% | Off-exchange volume (dark pool + OTC)
Sep 17, 2026
short_volume
Short Volume: QGEN — 61.9% short (0.4M / 0.7M)
Short: 441,569 | Exempt: 833 | TRF Vol: 713,697 | Short Ratio: 61.9% | Off-exchange volume (dark pool + OTC)
Sep 10, 2026
ftd
FTD: QGEN — 28,480 shares ($1.2M) failed to deliver
Settlement: 20260910, Price: $42.50, FTD Value: $1,210,400, QIAGEN NV SYNTHETIC SH REPURCH
Sep 9, 2026
ftd
FTD: QGEN — 14,600 shares ($0.6M) failed to deliver
Settlement: 20260909, Price: $42.38, FTD Value: $618,748, QIAGEN NV SYNTHETIC SH REPURCH
Earnings estimates
Forecast earnings per share and revenue by period — and whether estimates are rising.
| Period | EPS Est. | Range | Growth | 30d Rev | Up/Dn | Revenue | # |
|---|---|---|---|---|---|---|---|
| Current Q | $0.62 | $0.61–$0.64 | -3.3% | +0.4% | 0↑ 5↓ | $0.5B | 9 |
| Next Q | $0.65 | $0.64–$0.67 | 5.5% | -0.1% | 1↑ 4↓ | $0.6B | 9 |
| Current FY | $2.43 | $2.42–$2.45 | 2.3% | +0.0% | 4↑ 2↓ | $2.1B | 13 |
| Next FY | $2.61 | $2.57–$2.71 | 7.4% | +0.1% | 4↑ 6↓ | $2.2B | 13 |
Current-quarter EPS estimate — revision history
| When | EPS estimate | Change vs now |
|---|---|---|
| Current | $0.621 | — |
| 7d ago | $0.619 | +0.003 |
| 30d ago | $0.619 | +0.003 |
| 60d ago | $0.630 | -0.009 |
| 90d ago | $0.632 | -0.011 |
Short interest & halts
FINRA semi-monthly short positions, Reg SHO threshold status, and recent trading halts for QGEN.
Shares short
7,664,091
Settlement Sep 15, 2026
Change vs prior
+2.1%
Semi-monthly cycle
Days to cover
4.5
At avg daily volume
Of shares outstanding
≈3.7%
Estimate — not % of float
| Halted | Code | Reason | Status |
|---|---|---|---|
| Aug 24, 2026 | T1 | News Pending | Not resumed |
| Aug 24, 2026 | T3 | Resumption Scheduled | Resumed |